RE: FDA Minutes effect on SPI have to agree, Micr1. Last year SCT was almost viewed as a "sure thing", causing morons like me to take a bigger risk than prudent. Shareholders are much more tenative about it this year IMO.
I think it will take news on how they are going to fund phase III, partner or otherwise, or solid news on the TBI front before we have a chance of returning to last year's levels.
Just my opinion...been wrong before ;)
TW